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Abstract
Disseminated Mycobacterium avium complex (MAC) infection is a rare but severe disease mostly seen in patients with AIDS. It has been
previously described in patients suffering from other kinds of immunodeﬁciency (e.g. primary immunodeﬁciency diseases in children or
hairy cell leukaemia). We report two cases of disseminated MAC disease in young women with extended granulomatosis that revealed
a new form of severe immunodeﬁciency syndrome. Both clinical observations initially appeared to be very similar to WHIM syndrome
(Warts, Hypogammaglobulinemia, Infection, Myelokathexis), a rare immunodeﬁciency disease correlated with CXC chemokine receptor
4 (CXCR4) mutation leading to an impaired internalization of the receptor upon its ligand CXCL12. We investigated the CXCR4 status
of the lymphocytes in both patients and found a severe defect in CXCL12-promoted internalization but no mutation of its gene. More-
over, myelokathexis was not noted in bone marrow biopsies and therefore a diagnosis of WHIM syndrome could not be assessed. This
immunodeﬁciency syndrome associated with CXCR4 dysfunction was responsible for severe MAC infection in our patients, with a fatal
outcome in one case. It may be possible that these patients would have beneﬁted from early antimycobacterial infection or azythromy-
cin prophylaxis.
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Introduction
Mycobacterium avium complex (MAC) infection causes three
distinct forms of disease in humans: pulmonary disease in
adults with intact immunity, cervical lymphadenitis and dis-
seminated disease. Cellular immunity is a key part of host
immunity against MAC and severe depression of the CD4+
T-cell count is one of the greatest risks for failure of macro-
phage activation to eliminate intracellular MAC in patients
with AIDS. Humoral factors may also play a role in dissemi-
nated MAC disease. Although antibodies (Abs) against MAC
are not known to have a role in protection against this infec-
tion, they increase MAC killing in vitro [1]. Disseminated
MAC is mostly seen in patients with AIDS but also has been
described in children with primary immunodeﬁciency dis-
eases and in patients with hairy cell leukaemia. These clinical
observations suggest that immunodeﬁciencies centering on
cellular defects or macrophage/T-cell interactions predispose
to MAC infection [2,3]. We report two cases of young
women presenting with a new kind of immunodeﬁciency syn-
drome associated with CXC chemokine receptor 4
(CXCR4) dysfunction that could predispose to disseminated
MAC infection.
These two patients demonstrated clinical and biological
features close to those of a disorder linked to CXCR4 dys-
functions, the WHIM syndrome (Warts, Hypogammaglobulin-
emia, Infections, Myelokathexis), but myelokathexis was not
found in bone marrow (BM) biopsies.
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Materials and Methods
Patient 1
A 20-year-old Caucasian woman presented with a previous
history of warts on both hands (Fig. 1a) and clinical features
of extended sarcoidosis. Cutaneous, hepatic and mesenteric
biopsies conﬁrmed a gigantocellular granulomatosis without
caseous necrosis (Fig. 1b). Blood tests showed hypogamma-
globulinaemia (6 g/L) and leukopaenia (neutrophil count:
0.5 · 109/L, lymphocyte count: 0.6 · 109/L, monocyte count:
0.2 · 109/L). BM biopsy did not show myelokathexis,
myelodysplasia, granulomatosis or mycobacterial infection.
There was no evidence of lymphoma or infection with HIV,
hepatitis A-B-C viruses or cytomegalovirus), with blood tests
being negative. Anti-neutrophil cytoplasmic antibodies were
also absent. Steroid therapy was given for 6 months
without clinical improvement. Although the haematological
parameters remained identical, neutropaenia was corrected
with granulocyte-colony stimulating factor (G-CSF). Later,
abdominal masses became symptomatic and positron
emission tomography-computed tomography (PET-CT)
detected abnormal 18ﬂuorodeoxyglucose uptake (Fig. 1c).
Interferon a2-a was started at three infusions a week
(3 million units each), leading to dramatic clinical improve-
ment and PET-CT normalization (Fig. 1c). A few months
later, when the patient was still under prophylactic G-CSF
and trimethoprim-sulfamethoxazole, she developed severe
weakness, fever, loss of weight and a cough. Clinical exami-
nation and a CT scan revealed a large cervical lymph node
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FIG. 1. Clinical features of patient 1. (a)
Warts on the right hand. (b) Mesenteric
lymph node (· 20, hematoxylin/eosin/
saffron staining) showing a tuberculoid
reaction with central necrosis and periph-
eral agglutination of epithelioid cells on
Langhans cells (see arrow). (c) Fluorode-
oxyglucose (FDG)-positron emission tom-
ography imaging showing abnormal FDG
uptakes on a mesenteric mass at diagnosis
(left panel) and its normalization after
6 months of interferon a2-a therapy (right
panel).
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and lymphadenopathies in the coeliomesenteric, carenal and
mediastinal areas. A diagnosis of disseminated MAC infection
was made by lymph node biopsy and gastric and bronchial
ﬂuid aspiration. Furthermore, three blood cultures were
positive for MAC. Antibiotics were started but the patient
did not show a marked improvement after 4 months of
therapy.
Patient 2
A 21-year-old Caucasian woman, affected by warts on both
hands and feet ever since childhood, was hospitalized for
dyspnoea and weakness. Blood tests showed pancytopaenia
(haemoglobin 95g/L, neutrophil count 1.2 · 109/L, lympho-
cyte count 0.9 · 109/L, monocyte count 0.05 · 109/L and
platelet count 144 · 109/L) associated with normal BM
aspirate and hypogammaglobulinaemia (6 g/L). Hepatic tests
showed elevated liver enzymes (more than two-fold above
normal). A CT scan revealed centimetric mediastinal aden-
opathies. Bronchial biopsy showed gigantocellular granu-
loma without caseous necrosis and Ziehl Neilsen staining
was negative. Koch bacillus was not detected in bronchoal-
veolar ﬂuid and a tuberculin test was negative. Tests for
anti-neutrophil cytoplasmic antibodies were negative. Sar-
coidosis was suspected and steroid therapy was started,
leading to clinical improvement. Six months later, the pan-
cytopaenia worsened and the BM biopsy showed epitheli-
oid granulomata without necrosis but no myelokathexis.
Culture and PCR of BM and bronchoalveolar ﬂuid were
negative for for Mycobacterium. A CT scan demonstrated
pseudonodular liver and lung lesions. Steroid therapy
resulted in improvement in clinical symptoms and disap-
pearance of granulomata from the BM. Five months later,
when steroids were being tapered, she was hospitalized
again for haemophagocytic syndrome and treated with
cyclosporine plus methyl-prednisolone for 3 days (1g/day).
A few days later, fever reappeared with a worsened pan-
cytopaenia and the patient was treated with leukocyte
transfusion. A diagnosis of disseminated MAC infection was
made when blood and BM cultures were positive for
M. avium. Despite transient clinical improvement with anti-
mycobacterial therapy (rifabutin, ethambutol, pyrazinamide,
isoniazid and clarythromycin), the patient died of sinusal
mucormycosis infection. Autopsy showed acid-alcohol fast
bacilli in the pleura and liver.
CXCR4 mutation analysis
The ethical committee approved the protocol and patients
gave informed consent for genetic and functional studies.
Genomic DNA was extracted from peripheral blood mono-
nuclear cells (PBMCs) using either a standard phenol-chloro-
form protocol or the Wizard Genomic DNA puriﬁcation kit
(Promega, Madison, WI, USA). The coding sequence and
exon-intron boundaries (at least 50 bp) of CXCR4
(NM_003467.2) were sequenced in both directions with the
ABI PRISM Big Dye Terminator v1.1 Ready Reaction Cycle
Sequencing kit (Applied Biosystems, Foster City, CA, USA)
and run on an ABI PRISM 3100 Genetic Analyzer.
Functional evaluation of chemokine receptors
Flow cytometry analyses were carried out on a FACSCalibur
(Becton Dickinson, Rungis, France) using the anti-human
mAbs (from Becton Dickinson, Franklin Lakes, NJ, USA):
CD3 (clone SK7), CD4 (clone RPA-T4), CXCR4 (clone
12G5) and CCR7 (clone 3D12). Receptor internalization was
studied as previously described [4]. Brieﬂy, PBMCs were
incubated at 37C for 45 min with 200 nM CXCL12 (pro-
vided by Dr F. Baleux, Unite´ de Chimie Organique, Institut
Pasteur, Paris, France) or 6Ckine/CCL21 (R&D Systems,
Minneapolis, MN, USA), or for 75 min with 200 nM phorbol
12-myristate 13-acetate (PMA; Sigma Chemical, St Louis,
MO, USA). After one wash in acidic glycine buffer (pH 2.7),
levels of receptor cell surface expression were determined
using the corresponding phycoerythrin-conjugated mAbs in
combination with ﬂuorescent mAbs speciﬁc for T-cell anti-
gens. No receptor internalization was found when cells were
incubated at 4C in the presence of ligand. Receptor expres-
sion in stimulated cells was calculated: [receptor geometric
mean ﬂuorescence intensity (MFI) of treated cells/receptor
geometric MFI of unstimulated cells] ·100. 100% corre-
sponded to receptor expression at the surface of cells incu-
bated in medium alone.
Results and Discussion
We report two cases of systemic granulomatosis with myco-
bacterial infection in a context of immune deﬁciency. Both
patients showed clinical and biological similarities with
WHIM syndrome, including human papilloma virus-induced
warts, recurrent bacterial infections and a marked neutro-
paenia sensitive to G-CSF. None of them had a previous
family history of recurrent infectious diseases. WHIM syn-
drome has been linked to impaired CXCR4 desensitization
and internalization upon exposure to its ligand CXCL12
[4–9]. WHIM syndrome, most often inherited as an autoso-
mal dominant trait, is associated with heterozygous muta-
tions in CXCR4, which results in distal truncation of the
carboxyl-terminus of the receptor. Leukocytes from both
patients lacked detectable mutations in the CXCR4 gene and
displayed normal levels of membrane CXCR4 expression
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(Fig 2a,c). We assessed the ability of CXCR4 to be internal-
ized after CXCL12 stimulation in circulating T cells from
patients and healthy subjects. CXCL12-promoted internaliza-
tion of CXCR4 was markedly impaired in CD4+ (Fig 2b,d)
and CD8+ (data not shown) T cells from both patients. By
contrast, CXCR4 was readily internalized after PMA
treatment, strongly suggesting that the failure of CXCL12 to
promote the disappearance of CXCR4 from the cell mem-
brane results from an impaired internalization rather than a
persistent over-expression of the receptor. CCL21 efﬁ-
ciently induced internalization of CCR7, another chemokine
receptor essential for T-cell homing, in both patient and
control, suggesting that the impaired internalization of
CXCR4 relies on an anomaly affecting a downstream partner
with some selectivity for CXCR4. We previously docu-
mented that WHIM syndrome-associated CXCR4 dysfunc-
tions were also characterized in leukocytes from individuals
bearing a wild-type CXCR4 open reading frame and suffering
from the full clinical form of the disorder [10]. However,
despite the altered CXCR4 function, we cannot assess
WHIM syndrome diagnosis in the absence of myelokathexis,
the major feature of the disorder [5]. Moreover, the
immune defect affecting our two patients was marked by a
severe B-cell lymphopenia [patient 1: <1% of CD19+ cells,
98% of CD3+ T cells with 23% of CD4+ cells (266/lL), 42%
of CD8+ cells and 33% of cd CD3+CD4)CD8) cells; patient
2 : 2% of CD19+ cells, 94% of CD3+ T cells with 45% of
CD4+ cells (158/lL), 43% of CD8+ cells and 5% of cd
CD3+CD4)CD8) cells], and a severe defect in natural killer
cells (absolute counts of 12/lL and 1/lL in patients 1 and 2,
respectively), which has not been previously described in
WHIM syndrome patients. We also distinguished these two
cases from idiopathic CD4+ T-cell lymphocytopenia because
they showed additional neutropaenia, natural killer- and
B-cell depletion, granulomatosis of unknown signiﬁcance, and
were young at the age of diagnosis [11]. Systemic granulo-
matosis often leads to a diagnosis of sarcoidosis. In these
two patients, investigation of systemic granulomatosis led to
the identiﬁcation of a new kind of immunodeﬁciency corre-
lated with CXCR4 dysfunction. Steroid treatment failed,
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FIG. 2. Impaired CXCR4 internalization in T lymphocytes from patients 1 and 2. (a, c) Membrane expression of CXCR4 in CD4+-gated T cells
from unstimulated peripheral blood mononuclear cells of patient 1 (P1), patient (P2) and two independent healthy subjects (CTRL#1 and #2)
was determined by ﬂow cytometry using the phycoerythrin-conjugated 12G5 (empty histograms) or isotype control (grey histograms) monoclo-
nal antibodies. Similar results were obtained in CD8+-gated T cells and expression levels of CCR7 were in the same range at the surface of T
cells derived from patients and controls (data not shown). (b, d) Ligand-promoted internalization of CXCR4 or CCR7 was assessed in CD4+-
gated T cells from P1 and P2 vs. CTRL#1 and #2. Cells were either untreated or treated with 200 nM CXCL12, phorbol 12-myristate 13-ace-
tate or CCL21. Receptor levels are expressed as a percent of the expression in untreated cells. Results are the mean ± SD from one experi-
ment performed in duplicate (b) or of two independent determinations performed in duplicate (d). Statistically signiﬁcant differences between
patient and control cells are indicated (unpaired two-tailed Student’s t-test, **p <0.005).
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whereas interferon a2-a showed remarkable efﬁcacy in
patient 1. This drug has previously only had success in lym-
phoid granulomatosis with or without Epstein–Barr virus
infection [12,13]. In one of our patients, the disseminated
MAC infection had a fatal outcome and these kinds of
patients may beneﬁt from early antimycobacterial treatment
or even from azythromycin antibioprophylaxis.
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